Although previous studies pointed out new insights concerning the molecular classification of breast cancer, therapy is still based on the expression of hormone receptors (HR), estrogen receptors (ER), and progesterone receptors (PR), as well as the human epidermal growth receptor (HER2) [5]. This evidence concerns the gene ESR1 and breast cancer.